Animal‐friendly affinity reagents: replacing the needless in the haystack
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other animal-derived materials and reagents, such as Matrigel, collagen from diverse animal origins, and animal-derived antibodies, result in significant animal welfare concerns, which are in opposition to the original 3Rs principle.
“Other animal‐derived materials and reagents, such as Matrigel™ (a basement membrane preparation derived from the Engelbreth‐Holm‐Swarm sarcoma grown and propagated in mice), collagen from diverse animal origins, and animal‐derived antibodies, also results in significant animal welfare concerns, which are in opposition to the original 3Rs principle [17].”
From A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation (2022) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647 · see citing works
Flagged first, then by citations
Research works printed but not linked: 22
- [2]2. Leenaars, P.P. ... Assessment of side effects induced by injection of different adjuvant–antigen combinations in rabbits and mice Lab. Anim. 1998; 32:387-406 Crossref Scopus (75) PubMed Google Scholar
- [3]3. Marx, U. ... Monoclonal antibody production ATLA. 1997; 25:121-137 Google Scholar
- [4]4. Leenaars, M. ... The production of polyclonal antibodies in laboratory animals ATLA. 1999; 27:79-102 Google Scholar
- [6]6. Taussig, M.J. ... ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome Nat. Methods. 2007; 4:13-17 Crossref Scopus (216) PubMed Google Scholar
- [7]7. Hust, M. ... A human ScFv Ab generation pipeline for proteome research J. Biotechnol. 2011; 152:159-170 Crossref Scopus (111) PubMed Google Scholar
- [12]12. Dübel, S. ... Generating recombinant antibodies to the complete human proteome Trends Biotechnol. 2010; 28:333-339 Full Text Full Text (PDF) Scopus (88) PubMed Google Scholar
- [13]13. Marx, V. Calling the next generation of affinity reagents Nat. Methods. 2013; 10:703-707 Crossref Scopus (86) PubMed Google Scholar
- [14]14. Proetzel, G. ∙ Ebersbach, H. (Editors) Antibody Methods and Protocols Humana Press, 2012 Crossref Google Scholar
- [15]15. Aitken, R. (Editor) Antibody Phage Display Methods and Protocols Humana Press, 2009 Crossref Google Scholar
- [16]16. Hust, M. ... Construction of human naive antibody gene libraries Methods Mol. Biol. 2012; 907:85-107 Crossref Scopus (19) PubMed Google Scholar
- [19]19. Sidhu, S.S. ∙ Fellouse, F.A. Synthetic therapeutic antibodies Nat. Chem. Biol. 2006; 2:682-688 Crossref Scopus (125) PubMed Google Scholar
- [20]20. Frenzel, A. ... Generating recombinant antibodies for research, diagnostics and therapy using phage display Curr. Biotechnol. 2012; 1:33-41 Crossref Google Scholar
- [21]21. Altshuler, E.P. ... Generation of recombinant antibodies and means for increasing their affinity Biochemistry (Mosc.). 2010; 13:1584-1605 Crossref Scopus (26) Google Scholar
- [22]22. Borrebaeck, C.A.K. ∙ Ohlin, M. Antibody evolution beyond nature Nat. Biotechnol. 2002; 20:1189-1190 Crossref Scopus (31) PubMed Google Scholar
- [23]23. Söderlind, E. ... Recombining germline-derived CDR sequences for creating diverse single framework antibody libraries Nat. Biotechnol. 2000; 18:852-856 Crossref Scopus (281) PubMed Google Scholar
- [24]24. Igawa, T. ... Engineering the variable region of therapeutic IgG antibodies MAbs. 2011; 3:243-252 Crossref Scopus (134) PubMed Google Scholar
- [25]25. Bradbury, A. ... Beyond natural antibodies, the power of in vitro display technologies Nat. Biotechnol. 2011; 29:245-254 Crossref Scopus (447) PubMed Google Scholar
- [26]26. Schirrmann, T. ... Phage display for the generation of antibodies for proteome research, diagnostics and therapy Molecules. 2011; 16:412-426 Crossref Scopus (101) PubMed Google Scholar
- [27]27. Pershad, K. ... Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display Protein Eng. Des. Sel. 2010; 23:279-288 Crossref Scopus (45) PubMed Google Scholar
- [28]28. Dantas-Barbosa, C. ... Antibody phage display libraries: contributions to oncology Int. J. Mol. Sci. 2012; 13:5420-5440 Crossref Scopus (33) PubMed Google Scholar
- [29]29. Kirkpatrick, P. Specificity concerns with antibodies for receptor mapping Nat. Rev. Drug Discov. 2009; 8:278 Crossref Scopus (24) PubMed Google Scholar
- [30]30. Pozner-Moulis, S. ... Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model Lab. Invest. 2007; 87:251-260 Crossref Scopus (52) PubMed Google Scholar
Cited by
Sorted by citations
Ayoubi, R., Ryan, J., Biddle, M. S., Alshafie, W., Fotouhi, M., Bolivar, S. G., Ruiz Moleon, V., Eckmann, P., Worrall, D., McDowell, I., et al. (2023) · eLife · doi:10.7554/elife.91645.2 · Cited by 53 · see citing works
A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation
Cassotta, M., Bartnicka, J. J., Pistollato, F., Parvatam, S., Weber, T., D'Alessandro, V., Bastos, L. F., & Coecke, S. (2022) · Engineering in Life Sciences · doi:10.1002/elsc.202100167 · Cited by 33 · see citing works
Antibody affinity maturation by computational design
Kuroda, D., & Tsumoto, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8648-4_2 · Cited by 26 · see citing works
- Authors
- Gray, A. C., Sidhu, S. S., Chandrasekera, P. C., Hendriksen, C. F. M., & Borrebaeck, C. A. K.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 34
- Issue
- 12
- Pages
- 960-969
- ISSN
- 0167-7799
- Cited by
- 52
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
